World's Best Scientists 2026 revealed!
Kirsten R. Müller-Vahl

Kirsten R. Müller-Vahl

D-Index & Metrics

Neuroscience

D-Index
60
Citations
12158
World Ranking
3859
National Ranking
337

Overview

Kirsten R. Müller-Vahl is affiliated with Hannover Medical School in Germany. Their research spans multiple areas within psychology and medicine, with a focus on clinical psychology and cognitive neuroscience. Müller-Vahl has contributed substantially to understanding neuropsychiatric conditions and disorders related to obsessive-compulsive spectrum disorders, eating disorders, autism spectrum disorder, and cannabis research.

The scientist's main fields of study include:

  • Psychology
  • Medicine

More specifically, their subfields of research cover:

  • Clinical Psychology
  • Cognitive Neuroscience
  • Pharmacology
  • Psychiatry and Mental Health
  • Neurology

The primary topics of Müller-Vahl's work are:

  • Obsessive-Compulsive Spectrum Disorders
  • Eating Disorders and Behaviors
  • Autism Spectrum Disorder Research
  • Cannabis and Cannabinoid Research
  • Body Image and Dysmorphia Studies
  • Psychosomatic Disorders and Their Treatments
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Some of the recent papers by Müller-Vahl demonstrate their engagement in the clinical and pharmacological aspects of neurological and psychiatric disorders. Selected recent publications include:

  • "European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part II: psychological interventions" (2021) published in European Child & Adolescent Psychiatry
  • "European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment" (2021) published in European Child & Adolescent Psychiatry
  • "Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process" (2021) published in Journal of Cannabis Research
  • "European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part I: assessment" (2021) published in European Child & Adolescent Psychiatry
  • "Stop that! It's not Tourette's but a new type of mass sociogenic illness" (2021) published in Brain

Müller-Vahl frequently collaborates with other researchers in the field. Notable coauthors include:

  • Natalia Szejko
  • Carolin Fremer
  • Andreas Hartmann
  • Ewgeni Jakubovski
  • Alexander Münchau

The main venues in which Müller-Vahl publishes reflect a focus on psychiatry, neurology, and clinical psychology. Their frequent publication venues are:

  • European Child & Adolescent Psychiatry
  • Frontiers in Psychiatry
  • Movement Disorders Clinical Practice
  • F1000Research
  • Scientific Reports

Best Publications

  • Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders

    Phil H. Lee;Verneri Anttila;Hyejung Won;Yen-Chen A. Feng

  • Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders.

    Tamara Pringsheim;Michael S. Okun;Kirsten Müller-Vahl;Davide Martino

  • Interrogating the Genetic Determinants of Tourette’s Syndrome and Other Tic Disorders Through Genome-Wide Association Studies

    Dongmei Yu;Jae Hoon Sul;Fotis Tsetsos;Muhammad S Nawaz

  • The therapeutic potential of cannabis and cannabinoids.

    Franjo Grotenhermen;Kirsten Müller-Vahl

  • Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial.

    Kirsten R Müller-Vahl;Udo Schneider;Heidrun Prevedel;Karen Theloe

  • Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.

    K. R. Müller-Vahl;U. Schneider;A. Koblenz;M. Jöbges

  • Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders

    Tamara Pringsheim;Yolanda Holler-Managan;Michael S. Okun;Joseph Jankovic

  • Prefrontal and anterior cingulate cortex abnormalities in Tourette Syndrome: evidence from voxel-based morphometry and magnetization transfer imaging

    Kirsten R Müller-Vahl;Jörn Kaufmann;Julian Grosskreutz;Reinhard Dengler

  • Coprophenomena in Tourette syndrome.

    Roger D Freeman;Samuel H Zinner;Kirsten R Müller-Vahl;Diane K Fast

  • European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation

    Kirsten R. Müller-Vahl;Danielle C. Cath;Andrea E. Cavanna;Sandra Dehning

  • Rare Copy Number Variants in NRXN1 and CNTN6 Increase Risk for Tourette Syndrome

    Alden Y. Huang;Alden Y. Huang;Dongmei Yu;Dongmei Yu;Lea K. Davis;Jae Hoon Sul;Jae Hoon Sul

  • European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment.

    Veit Roessner;Heike Eichele;Heike Eichele;Jeremy S. Stern;Liselotte Skov

  • European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part II: psychological interventions.

    Per Andrén;Ewgeni Jakubovski;Tara L Murphy;Katrin Woitecki

  • Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia.

    Kirsten R Müller-Vahl;Hinderk M Emrich

  • Structural changes in the somatosensory system correlate with tic severity in Gilles de la Tourette syndrome

    Götz Thomalla;Hartwig R. Siebner;Melanie Jonas;Tobias Bäumer

  • New Insights into Clinical Characteristics of Gilles de la Tourette Syndrome: Findings in 1032 Patients from a Single German Center

    Tanvi Sambrani;Ewgeni Jakubovski;Kirsten R. Müller-Vahl

  • Altered modulation of intracortical excitability during movement preparation in Gilles de la Tourette syndrome

    Kirstin Heise;B Steven;G Liuzzi;G Thomalla

  • Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process.

    Arun Bhaskar;Alan Bell;Michael Boivin;Wellington Briques

  • Cannabinoids: possible role in patho‐physiology and therapy of Gilles de la Tourette syndrome

    K. R. Müller-Vahl;H. Kolbe;U. Schneider;H. M. Emrich

  • A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene.

    D Gadzicki;K Müller-Vahl;M Stuhrmann

  • Treatment of Tourette syndrome with delta-9-tetrahydrocannabinol (delta 9-THC): no influence on neuropsychological performance.

    Kirsten R Müller-Vahl;Heidrun Prevedel;Karen Theloe;Hans Kolbe

  • Health-related quality of life in patients with Gilles de la Tourette's syndrome†

    Kirsten Müller-Vahl;Ines Dodel;Norbert Müller;Alexander Münchau

  • Tourette's syndrome.

    Kirsten R. Müller-Vahl

Frequent Co-Authors

Alexander Münchau
Alexander Münchau University of Lübeck
Reinhard Dengler
Reinhard Dengler Hanover University of Applied Sciences and Arts
Alfons Schnitzler
Alfons Schnitzler Heinrich Heine University Düsseldorf
Christian Gerloff
Christian Gerloff University Medical Center Hamburg-Eppendorf
Veit Roessner
Veit Roessner TU Dresden
Christos Ganos
Christos Ganos Charité - University Medicine Berlin
Tobias Bäumer
Tobias Bäumer University of Lübeck
Danielle C. Cath
Danielle C. Cath Utrecht University
Manfred Stuhrmann
Manfred Stuhrmann Hannover Medical School
Benjamin M. Neale
Benjamin M. Neale Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Kirsten R. Müller-Vahl

Trending Scientists

Recently Published Articles